Details for New Drug Application (NDA): 017060
✉ Email this page to a colleague
NDA 017060 describes NOR-QD, which is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. Additional details are available on the NOR-QD profile page.
The generic ingredient in NOR-QD is norethindrone. There are twenty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the norethindrone profile page.
The generic ingredient in NOR-QD is norethindrone. There are twenty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the norethindrone profile page.
Summary for 017060
| Tradename: | NOR-QD |
| Applicant: | Teva Branded Pharm |
| Ingredient: | norethindrone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 017060
Suppliers and Packaging for NDA: 017060
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| NOR-QD | norethindrone | TABLET;ORAL-28 | 017060 | NDA AUTHORIZED GENERIC | Teva Pharmaceuticals, Inc. | 0480-3475 | 0480-3475-16 | 6 PACKAGE in 1 CARTON (0480-3475-16) / 28 TABLET in 1 PACKAGE |
| NOR-QD | norethindrone | TABLET;ORAL-28 | 017060 | NDA AUTHORIZED GENERIC | Actavis Pharma, Inc. | 52544-629 | 52544-629-28 | 6 PACKAGE in 1 CARTON (52544-629-28) / 28 TABLET in 1 PACKAGE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL-28 | Strength | 0.35MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB1 | RLD: | Yes | ||||
Complete Access Available with Subscription
